The survey of 1,300 Americans by diabetes-care firm 9amHealth found that when ranking their desired job benefits in order of importance, coverage for weight-loss drugs such as Ozempic and Wegovy ranked behind only employee-sponsored health care, flexible working hours, company equity and matching 401(k) contributions.
About 21% said they would be very likely or likely to change jobs if they could access coverage to the drugs. Among respondents who were taking the drugs, about 67% said coverage was either an extremely important or very important consideration for staying at their current job; another 23% said it was a somewhat important consideration.
[
add
]
[
|
|
...
]